Experiment 816592
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV INFUSION |
| Organism | Empty organism |
| Citation | BRUGAROLAS,A: PACHON,N: GOSALVEZ,M: LLANDERAL,AP: LACAVE,AJ: BUESA,JM: GRACIA MARCO,M:. (1978). PHASE I CLINICAL STUDY OF QUELAMYCIN.. 62() |
| Amount utilized | |
| Compound isolated | |
| Disease | PHASE I CLINICAL TRIAL OF 21 GOOD RISK PATIENTS:19 WITH NON-SMALL CELL CARCINOMA OF THE LUNG TWO PATIENTS WITH METASTATIC SARCOMA OBJECTIVE RESPONSES IN 3/19 PATIENTS WITH LUNG CANCER AND 1/3 WITH METASTATIC OSTEOGENIC SARCOMA DOSE LIMITING HEMATOLOGIC TOXICITY AND POTENTIALLY DANGEROUS CARDIOTOXICITY IN 8 PATIENTS |
| Dose amount | 125.0 MG |
| Number | 1 |
| Qualitative result | EQUIVOCAL |
| Animal | HUMAN ADULT |
| Per unit | SQ M BODY SURFACE |
| Dose expression | DOSE |
| Gender | GIVEN TO BOTH SEXES |